Pricing Log in Create free account

Aprea Therapeutics, Inc. (APRE) vs CNS Pharmaceuticals, Inc. (CNSP)

Aprea Therapeutics, Inc. and CNS Pharmaceuticals, Inc. are both Biotechnology companies. Aprea Therapeutics, Inc. and CNS Pharmaceuticals, Inc. are of similar size ($6.2M and $5.9M). Across the 9 metrics below, Aprea Therapeutics, Inc. leads on 7 and CNS Pharmaceuticals, Inc. on 2.

Valuation

Metric APRE CNSP Biotechnology median
P/E n/m n/m 10.60
P/S 97.70 n/m 9.40
P/B 0.82 1.46 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.65 n/m 0.66
EV/Sales (34.76) n/m 9.02
Earnings yield (134.54%) (606.43%) (32.88%)
Free cash flow yield (45.64%) (50.55%) (23.13%)

Profitability

Metric APRE CNSP Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (62.83%) (106.62%) (51.96%)
Return on assets (53.24%) (91.64%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APRE CNSP Biotechnology median
Revenue growth (TTM) (80.99%) — 6.76%
EPS growth (last fiscal year) 17.87% 92.34% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APRE CNSP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.67 5.86 4.97
Net debt to EBITDA 1.11 0.45 1.01

Dividend

Metric APRE CNSP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric APRE CNSP Biotechnology median
Market cap 6.24m 5.86m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack